Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | EYA3 | Q99504 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25683143 | 0.92 | GPR3 (0.39) | KDM4EHTTSMN1; SMN2UTS2RALDH1A1 | |
| SCHEMBL25682129 | 0.85 | SMN1; SMN2 (0.36) | KDM4EHTTCYP1A2CYP2D6SLC2A1 | |
| SCHEMBL25678272 | 0.81 | GPR3 (0.45) | KDM4EHTTSMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL25683145 | 0.81 | NPEPPS (0.40) | KDM4EHTTCYP1A2CYP2D6SLC2A1 | |
| SCHEMBL25996869 | 0.81 | UTS2R (0.40) | KDM4EHTTCYP1A2CYP2D6SLC2A1 | |
| SCHEMBL25682172 | 0.79 | ALKBH5 (0.41) | KDM4EHTTCYP1A2CYP2D6SLC2A1 | |
| SCHEMBL25682353 | 0.79 | CYP1A2 (0.48) | KDM4EHTTCYP1A2CYP2D6SLC2A1 | |
| SCHEMBL25997645 | 0.79 | ALKBH5 (0.35) | KDM4EHTTSMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL28137238 | 0.78 | LIPG (0.45) | CYP1A2PTPN1 | |
| SCHEMBL25682955 | 0.78 | ALKBH5 (0.36) | KDM4EHTTSMN1; SMN2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | CRY1, CCNE2, CRY2 | KDM4E 1997/4885HTT 854/4885CYP1A2 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.